2018 News Releases

Pacira Pharmaceuticals CMO Presents at FDA Advisory Committee Meeting Focused on Assessment of Opioid-Sparing Outcomes in Clinical Trials
11/16/18
Pacira Pharmaceuticals to Present at Healthcare Conferences in November
11/08/18
Centers for Medicare and Medicaid Services and American Dental Association Establish New Reimbursement for EXPAREL
11/02/18
Pacira Pharmaceuticals, Inc. Reports Third Quarter 2018 Financial Results
11/01/18
Aetna Offers Expanded Coverage for EXPAREL® in Select Ambulatory Surgical Centers 
10/30/18
Pacira to Report Third Quarter 2018 Financial Results on Thursday November 1, 2018
10/25/18
New Research Reveals Potency and Quantity of Opioids Prescribed for Postsurgical Pain Poses Danger to Patients, their Families and Friends
10/11/18
Pacira Pharmaceuticals to Present at the 2018 Wedbush Pacgrow Healthcare Conference
08/08/18
Pacira Pharmaceuticals, Inc. Reports Second Quarter 2018 Financial Results
08/02/18
Pacira to Report Second Quarter 2018 Financial Results on Thursday August 2, 2018
07/25/18
Pacira Reports Preliminary Net EXPAREL® Sales of $80.4 Million for Second Quarter of 2018
07/10/18
Pacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPAREL® in China
06/19/18
Aetna DocFind Directory Now Highlights Providers Offering Opioid Alternatives, Including EXPAREL®
06/15/18
MEDNAX National Medical Group and Pacira Pharmaceuticals Launch National Enhanced Recovery after Cesarean Surgery (ERACS™) Collaborative to Minimize Opioid Use
06/13/18
Pacira Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
05/31/18
Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results
05/03/18
Pacira Pharmaceuticals to Present at Two Healthcare Conferences in May
05/01/18
Pacira Pharmaceuticals Announces Timing for First Quarter 2018 Financial Results Webcast and Conference Call
04/26/18
Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® as a Nerve Block to Produce Regional Analgesia
04/06/18
Pacira Pharmaceuticals to Present at the 2018 Barclays Global Healthcare Conference
03/06/18
Pacira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
02/28/18
University of Tennessee Medical Center at Knoxville, Pacira Pharmaceuticals, and CQ-Insights Announce Collaboration to Minimize Opioid Use After Hernia Surgery
02/27/18
Pacira Pharmaceuticals Announces Timing for 2017 Financial Results Webcast and Conference Call
02/22/18
Pacira Pharmaceuticals to Present at the 2018 RBC Capital Markets Healthcare Conference
02/16/18
Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia
02/15/18
Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
02/14/18
FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
02/12/18
WellStar Health System and Pacira Pharmaceuticals Announce Partnership to Minimize Opioid Use and Standardize Outcomes Across Surgical Procedures
01/08/18
Pacira Pharmaceuticals Reports Preliminary 2017 Revenues of $286.6 Million
01/04/18
Pacira Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference
01/03/18